Condition
Medium Vessel Occlusion
Total Trials
5
Recruiting
5
Active
5
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 3 (2)
Trial Status
Recruiting5
Clinical Trials (5)
Showing 5 of 5 trials
NCT07668323Phase 3RecruitingPrimary
Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
NCT07746947Recruiting
PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Registry
NCT07357987Phase 3Recruiting
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT07185022Not ApplicableRecruiting
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion
NCT07302854Phase 2Recruiting
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion
Showing all 5 trials